chrisvoncsefalvay/vaers-outcomes huggingface dataset:
[9/19/22]-I took the shot on 9/19 at 7 pm and sat for 15 mins after. I took the booster shot in the left arm and the flu shot in the right arm. I felt fine after, just sore.  [9/20/22]- woke up at 9 am extremely bloated & gassy. Took some sips of coffee and that made it worse. I made ginger tea to help with my stomach, but starting around 2 pm I?ve been nauseous all day. I haven?t been able to eat and I just vomited around 8:30 pm. I got chills earlier about 5 o?clock & started feeling feverish. So far the flu like symptoms lasted from about 2 - 6 o?clock PM, but the nausea has lasted all day.
Patient was administered a dose after the published expiration date; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose after the published expiration date) and NO ADVERSE EVENT (No adverse event ) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose after the published expiration date) and NO ADVERSE EVENT (No adverse event ). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose after the published expiration date) and NO ADVERSE EVENT (No adverse event ) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event ) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose after the published expiration date).    Much information was not known. No concomitant medications were reported. No treatment medications were reported.
ARRHYTHMIA  ENLARGED HEART WALL EKG , STRESS TEST, ECHOCARDIOGRAM RX METOPROLOL 5 MG CONTINUE TO EXPERIENCE IRREGULAR HEARTBEAT
Migraines w aura, light and sound sensitivity, vertigo , tinnitus, migraines last 3-5 days and no medication will prevent or break the cycle. Vertigo so bad have to remain in bed and tinnitus so bad difficult ti hear when someone speaking or concentrate
Cough; labored breathing,Shortness of breath; Swelling of the left lymph node; Chills; Headache; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COUGH (Cough), DYSPNOEA (labored breathing,Shortness of breath), VACCINATION SITE LYMPHADENOPATHY (Swelling of the left lymph node), CHILLS (Chills) and HEADACHE (Headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced COUGH (Cough), DYSPNOEA (labored breathing,Shortness of breath), VACCINATION SITE LYMPHADENOPATHY (Swelling of the left lymph node), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue). On 15-Feb-2021, VACCINATION SITE LYMPHADENOPATHY (Swelling of the left lymph node), CHILLS (Chills), HEADACHE (Headache) and FATIGUE (Fatigue) had resolved. At the time of the report, COUGH (Cough) and DYSPNOEA (labored breathing,Shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: No new information.
Pain in balls of feet, pain in fingers and visible swelling at second joint of fingers in both hands, burning sensation and increased pain in joints in morning or any time after waking from sleep. Rheumatoid arthritis suspected. Symptoms were consistent until about November when they began to get milder until vaccine booster was taken on 1/24/22 when pain in hands and feet increased again. Morning pain and burning sensation tapered since November and stopped about 2 weeks ago and have not yet returned despite the booster.
Sore and  a lot pain in arm; feverish around shot sight.  Keflex for 7 days therapy and tramadol ordered on 5/7/2019.  Pt is still experiencing pain
no adverse event; Product temperature excursion issue; Poor quality vaccine administered; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (no adverse event) in a 47-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7173B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 16-Apr-2023, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 16-Apr-2023, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered).    No concomitant product was reported. The patient received Moderna booster before the 15 min thaw time. No treatment information was reported. It was unknown if the patient experienced any additional symptoms.
Patient received Pfizer CV19 bivalent prior to receiving complete initial series of Pfizer CV19 Monovalent vaccine.  Patient received only one single dose of the monovalent vaccine prior to administration of the bivalent. Noted in CDC document table 'COVID-19 Vaccine Interim COVID-19 Immunization Schedule for Persons 6 months of Age and Older' dated 10/21/2022 indicates COVID19 dose #2 can be either the monovalent or the bivalent. On further investigation noted that CDC recommends completion of the primary series with the same product.
Patient began having 'charley horses' muscle cramps about 10PM on 10-2-10 along legs/hips and shins - progressing to severe from midnite to 3AM next AM - both legs. Sunday, cramps continued although fading - stopped late Sunday nite (10-3-10). Patient, also felt flu-like symptoms. Better by Monday noon 10-4-10. Patient did state she has arthritis in knees and walked around mall quite a bit after vaccination. Initial redness and soreness at injection site gone by Monday also.
Death within 4 months of receiving the booster TDAP.    My sister passed away this past Sat, Oct 5th.  She was a healthy, happy 56-year-old women.  Her death makes no sense and we have not been provided with any answers from medical professionals.  In a nutshell, my sister started having minor pain in her head (ear area) in early June 2019, exactly two weeks after receiving the TDAP booster shot. The nerve pain that she had been experiencing had progressed to an unbearable state within a few short months. Before all this happened, she was a healthy, active woman.  She was never officially diagnosed with an illness/disease because her neurologist was not able to find an underlying cause after subjecting her to every logical test available. She was prescribed with pain medication, but the pain became too intense for her to bear. The doctor suggested that she might be suffering with Small Fiber Neuropathy (SFN) condition, but it was just a suggestion.  In just a few short months the symptoms progressed to the point where she felt burning pain throughout her entire body.  The pain was transient and intense. She was desperate for relief and answers. Approximately four weeks before her death her symptoms progressed to affect her autoimmune system and she began to have trouble swallowing, producing tears, breathing, heart palpitations, and digestive issues. She believed that she would not survive this pain and accompanying symptoms (she feared the autoimmune symptoms). After her own online research and was convinced that all these symptoms were as a result of a reaction, she had from the TDAP booster.  Everything she believed that was going to happen to her, did. I wonder if she was also right about the TDAP booster shot being the catalyst for her ultimate death.  Her body is with the coroner now and we are awaiting the autopsy report to understand the cause of death but I am wondering if there are any tests that can be performed that could determine if the TDAP  played any role in the symptoms she was experiencing as described above and her ultimate, untimely, early death.  Please call me so I can provide additional information. She visited the neurologist only twice and was told that her blood tests were perfect...all of the blood tests that were given to her came out clean. Yet, she passed away within four months of receiving the TDAP booster.
severe head ache, on off fever (100.7-102), muscle ache and fatigue (flu like), chills
Information has been received from a licensed nurse practitioner referring to unspecified patients of unknown age and gender. On an unknown date, the patients were vaccinated with improperly stored doses of VAQTA (lot # K018182, expiration date 12-FEB-2017, route and dose not provided). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Pt experienced redness, swelling and pain after injection. Physical therapy was ordered - visit with orthopedic doctor week of 02/14/2000.
I have a slight fever of 99; This Spontaneous report was received from contactable consumer (patient).   The patient unspecified age and gender received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported) via unknown route of administration, on 20Aug2021, as a dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medication were not reported. On 21Aug2021 patient had a slight fever of 99. Patient had taken two Ibuprofen and patient was trying to use like ice, so patient had an ice pad that helps. Outcome of event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Rash consistent with varicella approx. 50 lesions. No treatment necessary.
10 Moderna COVID-19 vials were in the freezer and experienced a temperature excursion; The caller confirms 18 patients were involved but the caller does not have any of that information with them to provide at this time.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (10 Moderna COVID-19 vials were in the freezer and experienced a temperature excursion) and EXPIRED PRODUCT ADMINISTERED (The caller confirms 18 patients were involved but the caller does not have any of that information with them to provide at this time.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (10 Moderna COVID-19 vials were in the freezer and experienced a temperature excursion) and EXPIRED PRODUCT ADMINISTERED (The caller confirms 18 patients were involved but the caller does not have any of that information with them to provide at this time.). At the time of the report, PRODUCT STORAGE ERROR (10 Moderna COVID-19 vials were in the freezer and experienced a temperature excursion) and EXPIRED PRODUCT ADMINISTERED (The caller confirms 18 patients were involved but the caller does not have any of that information with them to provide at this time.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.
PT REPORTS RASH, SWELLING AND TWITCHING IN BICEP AREA IN THE ARM THAT WAS INJECTED.
Pt is female who was evaluated pre-vaccine due to history of angioedema to Bactrim and Flagyl as a child. She received first COVID-10 Moderna vaccination on 1/2/21. Tolerated without issues, had body aches after, no fever. On 2/1/21, pt received second dose. 22 minutes into her 30 min monitoring she experienced headache (dull frontal with photophobia) and nausea. 5 minutes later began to have vocal changes and fullness in throat with difficulty swallowing. 25 mg oral Benadryl given without symptom resolution. EMS called and patient presented to the ED. Concern for anaphylaxis with airway involvement. Given epi-pen, Pepcid, steroids, 1 liter of fluid and another Benadryl...
Pt given 1st Moderna vaccine L arm at 9:20am.  Developed subjective sensation of numbness/tingling sensation of tip of tongue and lower lip, but no visible swelling. No issues breathing/swallowing or other sx.  As precaution, was given 50 mg PO benadryl at 9;43am.  Her sx fully resolved by 10;14am.  Pt was monitored until 10:28am.  Nml lung/mouth exam.   As precaution, epipen script sent to pharmacy by MD with instructions of how to use/when and to call 911/sma immediately..   Reviewed precautions and recs given this: Pt would prefer to have same second Moderna vaccine in 4 wks.  However, given this reviewed some of CDC statements/options:  1) to get non mRNA vaccine (J&J adenovirus vector) after at least 28 days 2) Possible referral to allergist prior 3) Potential of administering 2nd Moderna mRNA vaccine w/premedication of benadryl and prolonged monitoring.    Pt prefers the latter approach, but will get input from PCP when returns from vacation.
L upper arm pain starting a few days after a flu shot, spread up to shoulder.  Pt. unable to lift shoulder or reach back without pain.  Came to office for evaluation on 4/9/08.  Evaluation at that time felt to be consistent with adhesive capsulitis and patient referred to orthopedic surgeon.
According to the patiens, she had hives and echiness the next day after receiving the vaccination. Today the 14th of April, she showed up to the pharmacy and complained of severe leg cramps and multiple bruises in her legs and thighs. I advised her to go to the emergency room. She picked up her aspirin 81 mg .
2 days after Shingrix immunization was administered, patient started having a rash on neck, face, and around eyes. She stated no breathing issues. Patient went to urgent care and was prescribed prednisone and OTC benadryl. Pt is doing much better after 6 days, but has not completely recovered, when she came to the pharmacy to inform us what happened. She has a follow up appointment with her primary physician.
Was Horrible. I couldn't breathe. Like 6 months feeling Bad. Body pain, headaches. I was like dieing. Crazy and without health Insurance.
weakness; soreness at injection site; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), VACCINATION SITE PAIN (soreness at injection site) and FATIGUE (tiredness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 1. On 12-Mar-2021, the patient experienced ASTHENIA (weakness), VACCINATION SITE PAIN (soreness at injection site) and FATIGUE (tiredness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 14-Mar-2021, ASTHENIA (weakness), VACCINATION SITE PAIN (soreness at injection site) and FATIGUE (tiredness) had resolved.            Concomitant medications were not reported.
he had rash on his back, chest, legs and itching two days after the injection; itching two days after the injection; Initial information was received on 04-Mar-2020 regarding an unsolicited valid non-serious case from a consumer.  This case involves a 15 years old male patient who experienced he had rash on his back, chest, legs and itching two days after the injection and itching two days after the injection, while he received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The medical history included allergy to chemicals, dermatitis contact, reaction to preservatives and contrast media allergy.  Past medical treatment, vaccination and family history were not provided.  On 02-Feb-2020, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B (lot number and expiry date not reported) via an intramuscular route in the left arm for prophylactic vaccination.    On an unknown date, the patient developed non-serious rash on his back, chest, legs and itching two days after the injection (rash) and (pruritus) (2 days) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Laboratory data was not provided.  Final diagnosis was rash and pruritus.  The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]).  The outcome was reported as unknown for both the events.  Information on batch number was requested.
Patient got Pfizer vaccine outside of medical center on 4/7/2021. He developed optic neuritis on 4/15/2021. Working diagnosis is new onset multiple sclerosis.
Client was feeling al little bit anxious about vaccination symptoms and stating that she was having difficulty breathing.  Pt. instructed on relaxation, breathing techniques.  Pt. fully recovered.
Redness, swelling, hardness and itching at injection site that developed 8 days after receiving vaccine.
WAS GIVEN PNEUMOVAX THEN CALLED NURSE TRIAGE AT 4:47 PM THEN PRESENTED TO ER WITH INJECTION SITE BRUISED, TENDER TO TOUCH, BURNING SENSATION GOING DOWN R ARM THROUGH THE BONE AT 5:37.
Pt presented to the ER 03/30/16 reports bodyaches, fever, chills, sneezing, sore throat, and non-productive cough since 03/28/16 after vaccinations. L deltoid is warm to touch and slightly swollen at injection site. Fever and cough wheeze. Diphenhydramine 25 mg once.
Pt states has a "rash" feels bumpy & itchy on arms & legs & abdomen. Raised area on rt abdomen about 10-15 & rt. leg. Began Tues. NOC with itching. "Bumps" began Wed. Recommended BENADRYL.
0.5ml given instead of 0.25ml of moderna 2nd booster (4th shot). Patient exhibited no signs and symptoms of adverse reactions at time of administration.
Developed myocarditis 2 weeks after 2nd vaccine series. Bilateral lower extremity edema, worsening intermittent svt, chest pain with activity. Symptoms were transient and resolved in dec 2021
Shingles; bump moved to chest; Bump at the injection site moving to the chest and arm pit; mass under arm pit; Pain at the injection site; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (Shingles), MASS (bump moved to chest), VACCINATION SITE MASS (Bump at the injection site moving to the chest and arm pit), LYMPHADENOPATHY (mass under arm pit) and VACCINATION SITE PAIN (Pain at the injection site) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site). On 12-Feb-2021, the patient experienced MASS (bump moved to chest), VACCINATION SITE MASS (Bump at the injection site moving to the chest and arm pit) and LYMPHADENOPATHY (mass under arm pit). On 14-Feb-2021, the patient experienced HERPES ZOSTER (Shingles). The patient was treated with GABAPENTIN on 14-Feb-2021 for Shingles, at a dose of UNK dosage form and unknown (ANTIVIRALS) on 14-Feb-2021 for Shingles, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (Shingles), MASS (bump moved to chest), VACCINATION SITE MASS (Bump at the injection site moving to the chest and arm pit), LYMPHADENOPATHY (mass under arm pit) and VACCINATION SITE PAIN (Pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
only on my left side I had: muscle and joint pain; only on my left side I had: muscle and joint pain; earache; goopy eye; headache; exhaustion; pain at injection site; This is a spontaneous report from a contactable consumer (patient). A 56-years-old non-pregnant female patient received bnt162b2 (Pfizer, Solution for injection, Lot Number: EL3302), dose 1 via an unspecified route of administration, administered in arm left on 13Jan2021 13:30 (at the time of 56-years-old) as single dose for covid-19 immunisation. Medical history included Von Willebrand's and history of lyme disease, allergies: Peanut and latex. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received vitamin supplements within 2 weeks of vaccination. Concomitant medication included vitamin supplements. After first shot in left arm, only on my left side I had: muscle and joint pain, earache, goopy eye, headache, exhaustion, and pain at injection site from 12 hours to 36 hours after shot administered on Jan2021. The patient received treatment as epipen on hand. Therapeutic measures were taken as a result of events. The outcome of events was unknown.
2-3 days after vaccine pimples & follicles on arms, legs, one in face.
child given shots. Within 2 minutes while paperwork being finished, he stiffened, turned pale, clammy to uper extremities. Child place in recumbent position, in cool room. Vital signs monitored.
3-4" area of redness and hard lump, warm to touch 9-10-15 in the AM - persisted x 24 hours, treated with antibiotics and BENADRYL; immediate improvement.